TGA Approval

MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial (316671)

ARTG ID

316671

ARTG Name

MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial

Sponsor

Pfizer Australia Pty Ltd

ARTG Date

April 9, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

PFIZER AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/f855b4fd326dd58e27e4661a02f6bd43.pdf

https://medical-cdn.nocode.com/drug_tga/b7bae18c28e7b5d27e399262565d675d.pdf

Ingredient Name

gemtuzumab ozogamicin

Empowering clinical research with data-driven insights and AI-powered tools.

MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial (316671) - TGA 批准文号 | MedPath